APEIRON Biologics Announces Changes to Management and Supervisory Boards
DGAP-News: APEIRON Biologics AG / Key word(s): Personnel
01.06.2021 / 10:00
APEIRON Biologics Announces Changes to Management and Supervisory Boards
Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO)
Prof. Josef Penninger moves from the Supervisory Board to the newly created Scientific Advisory Board, which he will build up and lead as Chairman
APEIRON to propose Ulrich Granzer PhD as new member of the Supervisory Board at the upcoming Annual General Meeting
Vienna, Austria, 1 June 2021: APEIRON Biologics AG, a privately held biotechnology company developing novel immunotherapies for cancer and respiratory diseases, today announced changes to the Company s Management and Supervisory Boards.